Trending...
- New Release: 'The Invisible Alternative' Unveiled by Atrisk Corporation, Resilient
- From Real Estate to Reel Power: H.L Woods Carves His Legacy as a Cutting-Edge Visionary Filmmaker
- SacraPod Suites Unveils AI-Powered 'Work + Rest' Smart Hospitality Model for Retrofitting Underused Motels Across the U.S
MedVoice AI™ to collaborate with Mayo Clinic on the development of AI-powered technology to optimize the management of respiratory conditions
PITTSBURGH - PennZone -- MedVoice AI, Inc., a leader in conversational AI-powered healthcare, has entered into a know-how agreement with Mayo Clinic to develop innovative AI programs that offer real-time guidance and troubleshooting for patients managing cardiopulmonary conditions at home, such as COPD, asthma, or congestive heart failure.
Utilizing an exclusive right to two patents, this AI-powered innovation for at-home patient care will be the first-of-its-kind, seeking to arm patients, and their caregivers, with the guidance they need to manage their care.
The MedVoice system will gather information about the patient's health status, medical history, and comorbidities. A development goal is for it to also use real time data from the patient's medical devices and engage the patient in conversations to guide them through their at-home treatment. With use, patients could gain a deeper understanding of their at-home technology by asking questions and receiving real-time detailed answers. This empathetic and conversational troubleshooting could alleviate stress and provide vital support to successfully manage serious health conditions safely at home.
More on The PennZone
MedVoice technology seeks to initiate a conversation in place of blaring alarms.
For example, "Your pulse ox reading is lower than normal—is your oxygen nearby?" The patient could reply with questions: "How much lower is this reading than normal?" The goal is for the MedVoice powered device to provide real time responses, "Your previous normal readings were 94 to 95. This reading is 89. Are you feeling short of breath?"
This collaboration seeks to leverage Mayo Clinic's clinical expertise to define best practices that have the greatest impact on cardiopulmonary care outcomes.
Patient and practitioner focus groups at Mayo Clinic will help MedVoice ensure that every interaction with the program is empathetic, helpful, intuitive, and exceptionally user-friendly. MedVoice will incorporate these care solutions into its patented conversational AI system to deliver enhanced personalized care.
Hospitals and clinicians face an ever-increasing burden which means the need for at-home healthcare services is critical. However, at-home care can be overwhelming for the patient. Without proper training and support, this can lead to complications and life-threatening situations or unnecessary ER visits. At-home services and technology must be safe and effective to truly support a patient through the management of complex chronic healthcare.
More on The PennZone
MedVoice seeks to deliver a scalable and affordable solution to relieve the burden on clinicians and hospital systems while providing patients with 24/7 effective support.
"Health literacy, access to care, and effective self-management are critical challenges facing healthcare today," says Dr. Robert Gillio, co-founder of MedVoice AI, "Our collaboration with Mayo Clinic represents a significant step forward in addressing these challenges by creating a smart medical device ecosystem designed to provide comprehensive, personalized guidance to individuals in real-time."
About MedVoice AI, Inc.
MedVoice AI, Inc. is a pioneering healthcare technology company focused on revolutionizing healthcare through AI-driven smart medical devices. Its unique technology combines artificial intelligence with personalized, conversational healthcare—simplifying the management of serious chronic health conditions for patients and their providers.
Please note:
Mayo Clinic has a financial interest in the technology referenced in this press release. Any revenue received by Mayo Clinic will be used to support its not-for-profit mission in patient care, education, and research.
http://www.medvoice.ai
[END]
Utilizing an exclusive right to two patents, this AI-powered innovation for at-home patient care will be the first-of-its-kind, seeking to arm patients, and their caregivers, with the guidance they need to manage their care.
The MedVoice system will gather information about the patient's health status, medical history, and comorbidities. A development goal is for it to also use real time data from the patient's medical devices and engage the patient in conversations to guide them through their at-home treatment. With use, patients could gain a deeper understanding of their at-home technology by asking questions and receiving real-time detailed answers. This empathetic and conversational troubleshooting could alleviate stress and provide vital support to successfully manage serious health conditions safely at home.
More on The PennZone
- AI Visibility: The Key to Beating Google's AI Overviews and Regaining Traffic
- Stuck Doing Math or Figuring Out Life's Numbers? Calculator.now Makes It Stupidly Simple
- CLASS ACTION REMINDER: Berger Montague Advises Hims & Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Lawsuit by August 25, 2025
- Colbert Packaging Announces WBENC Recognition
- SHI Cryogenics Group Launches Highest-Capacity Single-Stage Cryocoolers to Date
MedVoice technology seeks to initiate a conversation in place of blaring alarms.
For example, "Your pulse ox reading is lower than normal—is your oxygen nearby?" The patient could reply with questions: "How much lower is this reading than normal?" The goal is for the MedVoice powered device to provide real time responses, "Your previous normal readings were 94 to 95. This reading is 89. Are you feeling short of breath?"
This collaboration seeks to leverage Mayo Clinic's clinical expertise to define best practices that have the greatest impact on cardiopulmonary care outcomes.
Patient and practitioner focus groups at Mayo Clinic will help MedVoice ensure that every interaction with the program is empathetic, helpful, intuitive, and exceptionally user-friendly. MedVoice will incorporate these care solutions into its patented conversational AI system to deliver enhanced personalized care.
Hospitals and clinicians face an ever-increasing burden which means the need for at-home healthcare services is critical. However, at-home care can be overwhelming for the patient. Without proper training and support, this can lead to complications and life-threatening situations or unnecessary ER visits. At-home services and technology must be safe and effective to truly support a patient through the management of complex chronic healthcare.
More on The PennZone
- DivX Empowers Media Enthusiasts with Free Expert Guides for Advanced MP4 Management
- Federated Hermes Premier Municipal Income Fund declares dividend
- Assent Expands Executive Team to Accelerate Global Growth & Innovation
- The World's Largest Green Economic Revolution Emerges as Nature, Tech, and Finance Converge
- Vinnetwork Unveils Decentralized AI Platform with Vinnetwork(VIN) Token to Challenge Tech Giants' Data Monopoly
MedVoice seeks to deliver a scalable and affordable solution to relieve the burden on clinicians and hospital systems while providing patients with 24/7 effective support.
"Health literacy, access to care, and effective self-management are critical challenges facing healthcare today," says Dr. Robert Gillio, co-founder of MedVoice AI, "Our collaboration with Mayo Clinic represents a significant step forward in addressing these challenges by creating a smart medical device ecosystem designed to provide comprehensive, personalized guidance to individuals in real-time."
About MedVoice AI, Inc.
MedVoice AI, Inc. is a pioneering healthcare technology company focused on revolutionizing healthcare through AI-driven smart medical devices. Its unique technology combines artificial intelligence with personalized, conversational healthcare—simplifying the management of serious chronic health conditions for patients and their providers.
Please note:
Mayo Clinic has a financial interest in the technology referenced in this press release. Any revenue received by Mayo Clinic will be used to support its not-for-profit mission in patient care, education, and research.
http://www.medvoice.ai
[END]
Source: MedVoice AI, Inc.
Filed Under: Health
0 Comments
Latest on The PennZone
- The Waite Launches: A Curated Motherhood Marketplace For Every Stage
- Affordable, High-Quality Care: Cheap Braces for Adults Available from Exeter Smiles in Reading
- NASA Collaborative Agreement for Supply of Thin-Film Solar Tech for Orbital Application to Advance Development of Thin-Film PV Power Beaming: $ASTI
- Sci-Fi Novel from Pittsburgh Author Explores Love, Power, & Humanity in an Age of Artificial People
- Exciting New Era of Sports, Entertainment & Gaming Innovation Spotlighted by Rebrand of Expanding AI Driven, Online Fan Engagement Company: SEGG Media
- Greenlight Networks to Acquire Loop Internet
- Finding the Best AC Repair Service in Philadelphia
- Service Ninjas Debuts First-of-Its-Kind "Membership" Platform for Home Service Pros
- BIYA Forecasts 2025 Surge with ¥300M ($41.8 M USD) in Revenue and ¥25M Profit from Cloud Based HR Solutions: Baiya Intl. Group (N A S D A Q: BIYA)
- Paul E. Saperstein Co. Announces Geographic Expansion of Auction Services
- Florida Broker Bent Danholm Featured in the Daily Mail's U.S. Real Estate Coverage
- Robin Launches Legal Intelligence Platform to solve intelligence gap in Fortune 500 legal teams
- Melissa B. Releases Digitally Independent: Empowering Music Artists with AI and Brand Strategy
- Consumer Accountability Alliance Issues Formal Notice Alleging Proximate Liability for Medical Harm
- Phillie Phanatic Joins the Together We Dance Foundation's Summer Dance Team to Celebrate Inclusion
- Utah Metal Fabricator Titan Forge Builds Momentum with Custom Steel Projects and Spiral Staircases
- Jason Koch: Pioneering the Future of Real Estate Development in New Jersey
- CLASS ACTION NOTICE: Berger Montague Advises Hims & Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Class Action
- e4health Earns 2025-2026 Great Place To Work Certification™ for Fourth Consecutive Year
- Bach and Beyond: Cellists Return to the Beach for 2nd Annual Bethany Beach Cellofest